Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Regeneron Pharmaceuticals, Inc. (REGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get REGN alertsJustin Holko is recorded as Head of Investor Relations at Regeneron Pharmaceuticals, Inc. (REGN). Justin Holko has spoken on 2 earnings calls across 1 company, most recently for Regeneron Pharmaceuticals, Inc. on November 4, 2021. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.
“Thank you for your interest in Regeneron Pharmaceuticals, and welcome to the Third Quarter 2021 Conference Call. An archive of this webcast will be available on our website.”
“Thank you for your interest in Regeneron Pharmaceuticals, and welcome to the second quarter 2021 conference call. An archive of this webcast will be available on our website.”
Biotechnology · Healthcare
Head of Investor Relations